Measles and Poliomyelitis Vaccines, Immunization, and Control - Kurstak, Edouard; SpringerLink (Online service) (Vienna : Springer Vienna : Imprint: Springer, 1993)
Editor's introduction Measles and poliomyelitis: vaccines, immunization, and control -- I. Measles Global Control -- 1. Challenges for the global control of measles in the 1990's -- 2. The experience with measles in the United States -- 3. Mass vaccination programme aimed at eradication of measles in Sweden -- 4. Identification of high risk groups for measles immunization -- 5. Is measles eradicable? -- 6. Safety of measles vaccines -- 7. Measles vaccines-one versus two doses: why and when -- 8. Cost-benefit analysis of a second dose measles inoculation of children -- 9. High-titer measles virus vaccines: protection evaluation -- 10. Recent approaches in the development of measles vaccines -- 11. Molecular biological basis of measles virus strain differences -- 12. Measles virus antigenic variations and the role of individual antigens in immunization -- 13. Cell-mediated immune response to measles virus -- II. Towards Poliomyelitis Eradication -- 14. Lessons from poliovirus control: strategies for eradication -- 15. Eradication of poliomyelitis: countdown or slowdown -- 16. The potential for poliovirus eradication -- 17. Poliovirus immunization situation in China -- 18. Epidemiologic and laboratory classification systems for paralytic poliomyelitis cases -- 19. Monitoring of the environment as a means of poliovirus surveillance -- 20. Criteria for the certification of poliomyelitis eradication -- 21. Poliovirus vaccine formulations -- 22. Inactivated and live attenuated poliovirus vaccines: mucosal immunity -- 23. Immunogenicity of poliovirus vaccines with special reference to the choice between oral and inactivated vaccines in developing countries -- 24. Optimal schedule for the administration of oral poliovirus vaccine -- 25. Poliovirus combined immunization with inactivated and live attenuated vaccines -- 26. Antigenicity and immunogenicity of inactivated poliovirus vaccine in combined vaccine trials -- 27. Studies aiming at improvement of inactivated poliovirus vaccine preparations -- 28. Development of candidates for new types 2 and 3 oral poliovirus recombinant vaccines -- 29. Intratypic differentiation of polioviruses -- 30. Natural evolution of oral vaccine poliovirus strains -- 31. Stability of attenuated poliovirus strain genotypes in the human intestinal tract.
Keywords: Vaccines; Internal medicine; Virology; Vaccine; Internal Medicine; Virology